Quality bridge infrastructure solutions critical to promoting stability in the region (Parsippany, New Jersey) – 24 July 2018 – Acrow
New Haven, CT, July 19, 2018 – Trevi Therapeutics, Inc. (“Trevi”), a late-stage biopharmaceutical company focused on developing Nalbuphine® ER
Bridges will allow uninterrupted passage during construction in the Îles Laval (Bolton, Ontario) – 30 April 2018 – Acrow Bridge,
Highlights challenges and opportunities for American businesses and EXIM’s role as an export credit agency (Parsippany, New Jersey) – 24
New Haven, CT, March 21, 2018 – Trevi Therapeutics, Inc. (“Trevi”), a late-stage clinical development company focused on developing Nalbuphine®
Wilton, CT, March 19, 2018 – Altus Capital Partners, Inc. (“Altus”), an investment firm focused on the North American manufacturing
